BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33714627)

  • 1. Overview of Gastrointestinal Lymphoproliferative disorders
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2021 Jul; 38(4):1-5. PubMed ID: 33714627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".
    Gonzalez RS; Raza A; Propst R; Adeyi O; Bateman J; Sopha SC; Shaw J; Auerbach A
    Arch Pathol Lab Med; 2021 May; 145(5):607-626. PubMed ID: 32886739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?].
    Ott G; Klapper W; Feller AC; Hansmann ML; Möller P; Stein H; Rosenwald A; Fend F
    Pathologe; 2019 Mar; 40(2):157-168. PubMed ID: 30019203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
    Soderquist CR; Bhagat G
    Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
    Wang XG; Yin WH; Wang HY
    Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Gastrointestinal Lymphomas.
    Weindorf SC; Smith LB; Owens SR
    Arch Pathol Lab Med; 2018 Nov; 142(11):1347-1351. PubMed ID: 30407861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract.
    Susan SH; Ng SB; Wang S; Tan SY
    Semin Diagn Pathol; 2021 Jul; 38(4):21-30. PubMed ID: 34016481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on B-cell lymphoproliferative disorders of the gastrointestinal tract.
    Plummer RM; Linden MA; Beckman AK
    Semin Diagn Pathol; 2021 Jul; 38(4):14-20. PubMed ID: 33863577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors.
    Alves de Castro JV; Costa FD; Ferreira CR
    Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of silver-binding nucleolar organizer regions (AgNORs) in lymphoproliferative disorders of gastrointestinal tract.
    Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
    Pathol Res Pract; 1994 Apr; 190(4):350-61. PubMed ID: 8078804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
    Burke JS
    Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
    Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
    Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphomas and Amyloid in the Gastrointestinal Tract.
    Ware AD; Wake LM; Fedoriw Y
    Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
    Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
    Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
    Owens SR
    Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms.
    Matutes E
    Int J Lab Hematol; 2018 May; 40 Suppl 1():97-103. PubMed ID: 29741263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recognition and classification of lymphoproliferative disorders of the gut.
    O'Malley DP; Goldstein NS; Banks PM
    Hum Pathol; 2014 May; 45(5):899-916. PubMed ID: 24613566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoproliferative Disorders of the Gastrointestinal Tract.
    Skinnider BF
    Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.